AAAAAA
Results:
1-15
|
Results: 15
Authors:
BUNTZEL J
SCHUTH J
KUTTNER K
GLATZEL M
Citation: J. Buntzel et al., RADIOCHEMOTHERAPY WITH AMIFOSTINE CYTOPROTECTION FOR HEAD AND NECK-CANCER, Supportive care in cancer, 6(2), 1998, pp. 155-160
Authors:
BUNTZEL J
KUTTNER K
FROHLICH D
GLATZEL M
Citation: J. Buntzel et al., SELECTIVE CYTOPROTECTION WITH AMIFOSTINE IN CONCURRENT RADIOCHEMOTHERAPY FOR HEAD AND NECK-CANCER, Annals of oncology, 9(5), 1998, pp. 505-509
Authors:
BUNTZEL J
GLATZEL M
WEINAUG R
SCHUTH J
FROHLICH D
KUTTNER K
Citation: J. Buntzel et al., INTENSIFIED RADIOCHEMOTHERAPY WITH AMIFOSTINE IN HEAD AND NECK-CANCER, Annals of oncology, 9, 1998, pp. 363-363
Authors:
BUNTZEL J
KUTTNER K
GLATZEL M
Citation: J. Buntzel et al., BONE METASTASES IN HEAD AND NECK-CANCER, British Journal of Cancer, 77, 1998, pp. 142-142
Authors:
BUNTZEL J
GLATZEL M
FROHLICH D
KUTTNER K
Citation: J. Buntzel et al., IMPORTANCE OF THE N-STATUS FOR PROGNOSIS AND TREATMENT IN GLOTTIC CANCER-PATIENTS, British Journal of Cancer, 77, 1998, pp. 1725-1725
Authors:
BUNTZEL J
KUTTNER K
RUSSELL L
SCHUTH J
GLATZEL M
Citation: J. Buntzel et al., INTENSIVE RADIOCHEMOTHERAPY (RCT) WITH AMIFOSTINE (A) IN HEAD AND NECK (H-AND-N) CANCER, European journal of cancer, 33, 1997, pp. 61-61
Authors:
BUNTZEL J
KUTTNER K
RUSSELL L
OSTER W
SCHUTH J
GLATZEL M
Citation: J. Buntzel et al., SELECTIVE CYTOPROTECTION BY AMIFOSTINE (A) IN THE TREATMENT OF HEAD AND NECK-CANCER WITH SIMULTANEOUS RADIOCHEMOTHERAPY (RCT), European journal of cancer, 33, 1997, pp. 852-852
Authors:
BUNTZEL J
ANDRA K
GLATZEL M
KUTTNER K
Citation: J. Buntzel et al., CHEMOPREVENTION WITH INTERFERON-ALFA AND 13-CIS RETINOIC ACID IN PATIENTS WITH ADVANCED HEAD AND NECK-CANCER, European journal of cancer, 33, 1997, pp. 870-870
Authors:
KUTTNER K
BUNTZEL J
ANDRA K
Citation: K. Kuttner et al., RESULTS OF MASTOIDITIS AND MASTOIDECTOMY, Laryngo-, Rhino-, Otologie, 75(2), 1996, pp. 65-69
Authors:
BUNTZEL J
GLATZEL M
KUTTNER K
SCHEFFLER B
OSTER W
FROHLICH F
Citation: J. Buntzel et al., ETHYOL(R) (AMIFOSTINE) PROVIDES MULTILINEAGE HEMATOPROTECTION AND PROTECTION AGAINST NONHEMATOLOGIC TOXICITIES INDUCED BY RADIOCHEMOTHERAPY(RCT) OF HEAD AND NECK-CANCER, Blood, 88(10), 1996, pp. 1781-1781
Authors:
BUNTZEL J
KUTTNER K
Citation: J. Buntzel et K. Kuttner, ROLE OF MEGESTROL-ACETATE IN THE TREATMEN T OF CACHEXIA IN PATIENTS WITH HEAD AND NECK-CANCER, Laryngo-, Rhino-, Otologie, 74(8), 1995, pp. 504-507
Authors:
BUNTZEL J
KUTTNER K
Citation: J. Buntzel et K. Kuttner, USES OF BRACHYTHERAPY IN PATIENTS WITH HE AD AND NECK-CANCER, Laryngo-, Rhino-, Otologie, 74(11), 1995, pp. 673-677
Authors:
BUNTZEL J
KUTTNER K
Citation: J. Buntzel et K. Kuttner, HEPATIC-INJURY DUE TO G-CSF APPLICATION, Onkologie, 18(1), 1995, pp. 54-56
Authors:
LIEBETRAU G
BUNTZEL J
PIELESCH W
MADER I
TREUTLER D
WIESNER B
Citation: G. Liebetrau et al., SIDE-EFFECTS ON THE INTERSTITIAL-TISSUE O F THE LUNG CAUSED BY METHOTREXAT, Allergologie, 17(2), 1994, pp. 65-70
Authors:
BUNTZEL J
LIEBETRAU G
Citation: J. Buntzel et G. Liebetrau, LUNG FIBROSIS CAUSED BY DIAMINODIPHENYLSU LFON, Allergologie, 17(2), 1994, pp. 71-73
Risultati:
1-15
|